Actorise 25MCG Injection is a formulation of the synthetic form of a hormone known as erythropoietin (EPO), which is principally involved in the production of red blood cells (RBCs). The active pharmaceutical ingredient in Actorise is Darbepoetin alfa, which is an analog of human erythropoietin, created through recombinant DNA technology. Actorise is intricately designed to stimulate the bone marrow to enhance the production of RBCs, thereby increasing the oxygen-carrying capacity of the blood. Clinically, it is employed in situations where there is a deficiency or suppression of endogenous EPO, commonly in chronic kidney disease (CKD) or as a consequence of certain therapies like chemotherapy that induce anemia. Administered intravenously or subcutaneously, Actorise is a vital therapeutic agent that addresses anemia without requiring blood transfusions, which can be associated with risks such as infection transmission or immune reactions.